A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix An NRG Oncology/Gynecologic…

Overview of attention for article published in International Journal of Gynecological Cancer, March 2015

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 7,476 followers.

Most Popular: A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim i... http://t.co/Ch0dLJMKYs

Table of Contents: A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgras... http://t.co/Ch0dLJMKYs

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.